Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
0.8100
-0.0100 (-1.22%)
Mar 12, 2026, 4:00 PM EDT - Market closed
Immuron Market Cap
Immuron has a market cap or net worth of $7.18 million as of March 12, 2026. Its market cap has decreased by -36.44% in one year.
Market Cap
7.18M
Enterprise Value
237.50K
1-Year Change
-36.44%
Ranking
Category
Stock Price
$0.81
Market Cap Chart
Since June 9, 2017, Immuron's market cap has decreased from $28.10M to $7.18M, a decrease of -74.44%. That is a compound annual growth rate of -14.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 6.70M | 48.89% |
| Dec 31, 2025 | 4.50M | -53.61% |
| Dec 31, 2024 | 9.70M | -9.35% |
| Dec 29, 2023 | 10.70M | -9.32% |
| Dec 30, 2022 | 11.80M | -16.90% |
| Dec 31, 2021 | 14.20M | -50.00% |
| Dec 31, 2020 | 28.40M | 91.89% |
| Dec 31, 2019 | 14.80M | -28.50% |
| Dec 31, 2018 | 20.70M | 20.35% |
| Dec 29, 2017 | 17.20M | -38.79% |
| Jun 9, 2017 | 28.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaCyte Biotech | 7.46M |
| GridAI Technologies | 7.40M |
| Alaunos Therapeutics | 7.34M |
| Mustang Bio | 6.87M |
| Creative Medical Technology Holdings | 6.78M |
| Addex Therapeutics | 6.72M |
| BioRestorative Therapies | 6.60M |
| Evogene | 6.60M |